TScan Therapeutics (TCRX) Receivables - Net (2023)
TScan Therapeutics (TCRX) has disclosed Receivables - Net for 1 consecutive years, with $31.9 million as the latest value for Q2 2023.
TScan Therapeutics (TCRX) has disclosed Receivables - Net for 1 consecutive years, with $31.9 million as the latest value for Q2 2023.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month